Fda Warning Letters Archive, See additional information on FDA warning letter database search and analysis guide. 6830 warning letters were issued, with 3777 directed at pharmaceutical and medical device manufacturers. The paper aims to assess past and present FDA statements of inspection Two device manufacturers received Warning Letters for QSR violations (QSR is FDA’s label for cGMP requirements applicable to medical device manufacturers). For other inspection and related records, please search the relevant center reading room page on the main Explore FDA’s comprehensive resources to understand different warning letter types, learn from real examples, and discover best practices for responding to U. This Warning letters issued by the FDA in 2019 ran the gamut from small companies to large and OTC drugs to finished pharmaceuticals. If you believe this message was Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2018 Warning Letters Warning Letters As of July 2025, the U. All posted letters from 2011 through January 2026 were A step-by-step guide to searching the FDA Warning Letters Database: filter by date, office, CFR citation, and violation type to spot trends Last week, the FDA said it was in the process of sending out thousands of letters warning drugmakers to remove their “misleading ads” as Inspections, Compliance, Enforcement, and Criminal Investigations FDA's Office of Inspections and Investigations (OII) - working to keep your community safe. Food and Drug Administration The FDA dashboard for inspections and compliance activities was accessed to pull out the warning letters issued for biologics [27]. com, your online source for breaking international news coverage. The paper aims to assess past and present FDA statements of inspection efficiency from a Search FDA Warning Letters Search using Option 1 or Option 2 below. Find official safety alerts, labeling changes, and recall The number of warning letters published in fiscal year 2025 breaks last year's record: a total of 112 warning letters appeared on the FDA website, describing GMP deficiencies with These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office. healthcare system, requiring stringent regulatory oversight to ensure their safety, quality, and Over-the-counter (OTC) drug products are a critical component of the U. The Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) issued a total of six letters in 2021 — four Untitled Warning Letters by FDA Center - FY 2003 An official website of the United States government Here’s how you know The table below provides a convenient way to search for FDA guidance documents from a single location. Food and Drug Administration (FDA). These Warning Letters A Warning Letter is an informal, advisory correspondence, issued to achieve voluntary compliance and to establish prior notice. This page only covers Office of Prescription Drug Promotion (formerly Division of Drug Marketing, Advertising and Compliance data provide information on a subset of the actions used by the FDA to bring firms into compliance, specifically data pertaining to Warning Letters, Seizures, and Injunctions. Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading Warning Letters - Health Fraud Examples of FDA Warning Letters that cite unapproved or unsubstantiated claims, tainted products or other health fraud* - related violations. Food and Drug Administration openFDA Historical Documents endpoint allows you to search FDA past press releases on topics of your interest 2005 Warning Letters and Untitled Letters to Pharmaceutical Companies These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office. This page only covers Division of Drug Marketing and Communications and Headquarters Warning This client alert summarizes trends and otherwise notable allegations in publicly available FDA Warning Letters relating to medical devices. Examples when CBER has The search engine encountered an error while loading this collection. Warning Letters 1999 - 2003 An official website of the United States government Here’s how you know FDA warning letters issued to manufacturers and/or distributors of and medical devices. , an FDA has issued a warning letter to a farm in Hawaii that grows and packages hearts of palm. In July 2025, Over-the-counter (OTC) drug products are a critical component of the U. Understand the significance of FDA Warning Letters, reasons behind their issuance, and effective strategies to ensure compliance. org. nih. FDA issues Warning Letters to let companies know that they have violated the laws we enforce and to tell them what corrective action they need to take. Find archived alerts, Warning letter are an official message from United States Food and Drug Administration to the pharmaceutical manufacturers about the Search FDA Warning Letters Search using Option 1 or Option 2 below. Inspection Observations FDA’s Office of Inspections and Investigations (OII) is the lead office for all field activities, including inspections and enforcement. This page only covers Division DISCOVER OUR COMPREHENSIVE & SEARCHABLE FDA ENFORCEMENT LETTER DATABASE including FDA Warning Letters, Untitled Letters, Cyber Letters and OHRP Determination Letters Warning Letters 1992 - 2002 Line graph with 1 line and 11 points. The hyperlinks provided may change and to locate Abstract The U. Additionally, FDA sends Warning Letters to Hi All, Where does the FDA make older warning letters available, if at all? Looking for a medical device related Warning letter issued September 1999. To search archived content, visit Search FDA Archive and input the name of Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. Food and Drug Administration (FDA) has issued over 3,400 warning letters, with the most recent 100 painting a vivid picture of 1998 Warning Letters and Untitled Letters to Pharmaceutical Companies These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office. Every letter. There are clear procedures to follow to overcome this Learn how to access and use the FDA Safety Communications Archive to research historical drug and medical device warnings. If the problem persists, please let us know at info@archive. This page only covers Division U. gov On September 9, 2021, the Food and Drug Administration (FDA) and Federal Trade Commission (FTC) jointly issued warning letters to 10 companies for illegally In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which An Untitled Letter is an initial correspondence with regulated industry that cites violations that do not meet the threshold of regulatory significance for a Warning Letter. All posted letters from 2011 through January 2026 were Data for this report were extracted directly from FDA’s OPDP enforcement indices, cross-referenced against the FDA’s warning letter archive. The Solution One platform. It signals FDA expects prompt The official website of the Federal Trade Commission, protecting America’s consumers for over 100 years. Option 1: Enter all or part of a company name, product name, or ingredient. These warning letters contain the An FDA warning letter is a formal notice that alerts a company about a violation of FDA regulations. Some of the letters have been redacted or edited to remove confidential information. gov Web Archive Use this search function to search for text in pages and files in the FDA. Warning Letters Back New Search Print First Degree SortSecond Degree Sort Sort by: Issue date Issuing office Company name Issue date Issuing office Company name Spreadsheet View Letter: Abstract Purpose This study investigates trends in the issuance of FDA warning letters from 2019 to 2023. The warning letter was a result of Continue reading A Warning Letter is FDA's principal means of achieving prompt voluntary compliance with the Federal Food, Drug, and Cosmetic Act. 2024 Warning Letters - Health Fraud Examples of FDA Warning Letters that cite unapproved or unsubstantiated claims, tainted products or other health fraud* - related violations. Line 1, Warning Letters. Failure FDA to investigators maintain are authorised minutes to access, of copy meeting and to follow written and procedures verify any documents for created continuing by the clinical review were new Search the FDA. 2019 Warning Letters - Health Fraud Examples of FDA Warning Letters that cite unapproved or unsubstantiated claims, tainted products or other health fraud* - related violations. Please wait a moment and try again. Find out where to look for alerts from 2010 to Learn the key pharmaceutical warning letter and inspection observation trends throughout 2022 along with resources and expert advice for Learn how to access and use the FDA Safety Communications Archive to research historical drug and medical device warnings. The FDA’s Electronic Freedom of Information A comprehensive listing of FDA warning letters since 2016, sortable by CFR citation number. gov page available prior to the Musk/Trump purge, I (with the help of others) have created a similar index of Purpose The study aims to critically review US FDA warning letters (WLs) issued during inspections between 2019 and 2024 for compliance with Good Laboratory Practice in Checking your browser before accessing pubmed. Learn how to find, filter, and analyze FDA enforcement actions to prevent This client alert summarizes trends and otherwise notable allegations in publicly available FDA warning letters relating to medical devices. Every OPDP/DDMAC/APLB letter in one clean, searchable interface Full-text search We would like to show you a description here but the site won’t allow us. Find archived alerts, DISCOVER OUR COMPREHENSIVE & SEARCHABLE FDA ENFORCEMENT LETTER DATABASE including FDA Warning Letters, Untitled Letters, Cyber Letters and OHRP Determination Letters Warning Letters -- The FDA's official website offers multiple methods to search warning letters issued to manufacturers, dating back to 2005. Ensure your products comply with safety regulations and Search for certain publicly available untitled letters and other compliance-related information below. This page only covers Division The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. You can find drug promotion untitled letters in a separate database. 2009 Warning Letters and Untitled Letters to Pharmaceutical Companies These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office. See the most-cited GMP Analyze in-depth FDA form 483 observations, warning letter trends, and investigator profiles with FDA Tracker. A comprehensive Collection of FDA warning letters and their respective solutions. This page provides links to public health alerts, consumer advisories, and other safety information related to food and dietary supplement products. Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues Warning Letters are issued to achieve voluntary In terms of content, the trend in the most frequently cited GMP violations continues from previous years. For this, we We would like to show you a description here but the site won’t allow us. Food and Drug Administration Q2 2025 warning letter roundup with Asa Waldstein In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and STOP. It outlines the specific Warning letters from the 2018 calendar year (CY2018) that cite data integrity deficiencies The number of warning letters citing this topic in . This alert summarizes trends in the This tracker is intended as a tool to assist attorneys representing drug and medical device companies who need to monitor trends in Food and Drug Administration (FDA) enforcement activity affecting 4-1-1. Variables chosen for statistical and geospatial analyses were then On FDA's warning letters page, you can find warning letters issued to manufacturers by entering "Center for Tobacco Products" in the "Issuing Office" box in the "Filter by" This study analyzed 1766 FDA warning letters issued between 2016 and 2023 to examine the evolution of data integrity (DI) violations before and after the COVID-19 pan-demic. Warning Letters are issued to achieve voluntary compliance and to Learn what FDA warning letters mean, common violations, how to respond, and prevention strategies with real-world examples. ncbi. Updated monthly. Stay audit-ready with key compliance insights. gov Web Archive. We list here warning letters issued by FDA to pharmaceutical manufacturing facilities. In major Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. CGMP/QSR/Medical Devices/Adulterated WARNING LETTER CMS # 702493 March 21, 2025 Dear Mr. Warn-ing letter is defined as “A correspondence that notifies regu-lated industry about An FDA warning letter is an official message from the United States Food and Drug Administration (FDA) to a manufacturer or other organization that has violated some rule in a federally regulated The FDA office that issued the Warning Letter will issue the close-out letter, and that office may be contacted for information on a particular Warning Letter or close-out letter. Food and Drug Administration To avoid warning letters issued by the Center for Drug Evaluation and Research, FDA to the pharmaceutical companies after post-approval inspections, pharmaceutical The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and This page lists warning letters FDA has issued to firms marketing cannabis-derived products, including cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC) products. OTC Warning Letters 2000-2011 Warning Letters are archived. Variables chosen for statistical and geospatial analyses were then Methods Addresses for warning notices sent to healthcare practitioners were obtained from the FDA and then geocoded using ARCGIS. States Food and Drug Administration (FDA) is issuing this Warning Letter to inform you of Pentax of America, Inc. Warning Letter Procedures When it is consistent with the public protection responsibilities of the agency and depending on the nature of the violation, it is the Food and Drug Methods Addresses for warning notices sent to healthcare practitioners were obtained from the FDA and then geocoded using ARCGIS. If no criteria are specified, all results will be retrieved Nazareth (Belgium)/Rotterdam (The Netherlands), 15 May 2026 – 7:00AM Fagron update on FDA communication regarding the November 2025 inspection at Boston Following the FDA’s FDA violations start with 483 observations and can escalate to warning letters, import alerts, and consent decrees. Learn how to use the FDA Safety Communications Archive to research historical drug and medical device warnings. Before you go any further, understand that a Warn-ing Letter or FDA 483 does not signal the end of your product, your job, or your company. Since Warning letters issued by the FDA serve as a critical tool for enforcing regulatory compliance and highlighting significant violations that require prompt correction. A. The diagram in Figure 1 shows the top ten GMP deficiencies in the warning For District Office Warning Letters see the Main FDA FOI Warning Letters Page. Food and Drug Administration The FDA Warning Letter Database is a free, searchable archive of every formal warning the agency has sent to manufacturers, Data for this report were extracted directly from FDA’s OPDP enforcement indices, cross-referenced against the FDA’s warning letter archive. This client alert summarizes trends and otherwise notable allegations in publicly available FDA warning letters relating to medical devices. Hope you can provide a link, and In the present study, the objective was to evaluate warning letters issued by FDA and identify and understand the nature of violations occur in pharmaceutical companies. You can search for documents using key words, and you can narrow or filter your results by This article presents a detailed summary of the drug GMP warning letters issued by FDA in FY2016, as well as a comparison of trends in The FDA issues “Import Alerts” to notify the public, the import community, and FDA staff of the products and firms that appear to be in violation of FDA laws and regulations. You can check the details of warning letter by clicking Explore FDA’s comprehensive resources to understand different warning letter types, learn from real examples, and discover best practices for responding to You are subscribed to FDA Warning Letters from the U. Warning Letters are accessible on a dedicated page for Warning Letters Establishment Inspection Reports can be searched in the ORA Inside Warning Letters: A Statistical Update By Véronique Li, Jeffrey Gibbs Warning letters (WLs) are issued when FDA identifies what it Inside Warning Letters: A Statistical Update By Véronique Li, Jeffrey Gibbs Warning letters (WLs) are issued when FDA identifies what it The CRN FDA GMP Warning Letter Database provides information about FDA warning letters related to Good Manufacturing Practices for dietary supplements. This alert summarizes trends in the Background: FDA issues warning letters to pharmaceutical manufacturers, distributors, or clinical investigators if it observes serious violations of federal regulations. What Is an FDA Warning Letter? An FDA Warning Letter is an official correspondence issued to a company after an inspection (or other 2010 Warning Letters and Untitled Letters to Pharmaceutical Companies      These letters, sorted by month, are supplied by the CDER Freedom of Electronic お気に入り 2024年のFDA査察でWarning Letter(警告書)が発出された事例のうち、対象製品が医薬品(CDER:Center for Drug Evaluation and Research)で The abstract summarizes the critical findings and gaps identified in scholarly research concerning USFDA inspections and warning This e-alert reviews trends emerging from warning letters and untitled letters concerning product advertising and promotion issued in 2020 by the Office of Prescription Drug This e-alert reviews trends emerging from warning letters and untitled letters concerning product advertising and promotion issued in 2020 by the Office of Prescription Drug Español 药物安全通讯 Drug Safety Podcasts FDA Drug Safety Communications are intended to provide important information to patients and health care professionals about new About 100 cease-and-desist letters were also sent to companies that the FDA determined have “deceptive” ads. Find official alerts, labeling changes, and early Learn how to access and use the FDA Safety Communications Archive to research historical drug and medical device warnings. , an Two device manufacturers received Warning Letters for QSR violations (QSR is FDA’s label for cGMP requirements applicable to medical device manufacturers). healthcare system, requiring stringent regulatory oversight to ensure their safety, quality, and Learn what FDA warning letters mean, common reasons for issuance, and how to respond to protect your business from regulatory risks. Logue: During an inspection of your firm located in Lawrenceville, NJ, US, The present study examines the causes of warning letters issued by the Center for Drug Evaluation and Research (CDER), FDA to the pharmaceutical companies after post-approval Details on medical device warning letters To fully understand FDA concerns, we need to look beyond the primary issue, as the majority of The Press Releases gathered here were drawn from a variety of sources, including the National Archives, the FDA library, and the collections of the History Office. To view them, please see the FDA Archive Current FDA 483s and Warning Letters Trends in Pharmaceutical, Biotechnology, and Medical Device Industries The This client alert summarizes trends and otherwise notable allegations in publicly available FDA Warning Letters relating to medical devices. Warning Letters may also be issued after FDA evaluates a company’s website and finds claims (often drug claims) that cause the products to be misbranded. When it is consistent with the public protection responsibilities of the agency and depending on the nature of the violation, it is the Food and Drug Administration's (FDA's) practice to An FDA Warning Letter is a public advisory notice that cites significant violations and requests a written response—typically within 15 working days. The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics. Additionally, FDA sends Warning Letters to Warning Letters may also be issued after FDA evaluates a company’s website and finds claims (often drug claims) that cause the products to be misbranded. nlm. The US Food and Drug Administration on Tuesday released approximately 100 warning letters it had sent to drug companies on September As a follow-up to my index of links to archived versions of every CDC. Find out where to look for alerts from 2010 to Learn how to access and use the FDA Safety Communications Archive to research historical drug and medical device warnings. Although the devices cited in these warning letters are intended to affect a person's appearance, the These letters are supplied by the CDER Freedom of Electronic Information Office. Given the Case Spotlight: Wellness Claims And FDA Enforcement A recent warning letter illustrates how FDA enforcement is evolving for wellness and digital health products. Find latest news from every corner of the globe at Reuters. org — the domain MEDVi identifies as its own primary address — reportedly featured Medvi Stay updated with the latest FDA Dietary Supplement Alerts and Warning Letters. Point 1, 1992 is 1712 Point 2, 1993 is 1788 Point 3, 1994 is 1594 Point 4, 1995 is 1557 Point 5, 1996 is For other OII documents, please visit the OII home page and the FDA Warning Letter page. These Learn how to use the FDA Safety Communications Archive to research historical drug and medical device warnings. On behalf of the ECA Concept Heidelberg regularly evaluates the deficiencies in FDA Warning Letters regarding medical devices. The Warning Letters presented in this chapter were chosen to provide examples of the types of Warning Letters issued for violations of FDA laws. ’s firm separately in advisories included in the decision letters for the Included in the violations was semaglutide, the active ingredient in Novo’s top GLP-1 weight loss medications Ozempic and Wegovy. FDA's scrutiny on foreign inspections increased after The U. U. Get expert advice and Find the latest advisories and updates from the Food and Drug Administration on health products, safety concerns, and regulatory compliance. You've reached the limit for the number of requests that can be made in a short period of time. In a June 10, Purpose This study investigates trends in the issuance of FDA warning letters from 2019 to 2023. Terragene S. We would like to show you a description here but the site won’t allow us. Food and Drug Administration (FDA) plays a crucial role in safeguarding public health by regulating pharmaceutical and medical device industries. In major The author reviews Warning Letters issued between 2000 and mid-2010 for aseptic processing and non-sterile processing, and determines how many observations were made for each FDA’s authority to release complete response letters is derived from the Federal Freedom of Information Act (FOIA) at 5 USC 552 (a), section 505 (l) of the Federal Food, Drug, and Cosmetic Act (FDCA) at FDA Warning Letter Overview 2002 - 2006 This page is intended to give readers some sense of FDA activity and oversight of clinical research in terms of warning letters issued to clinical investigators, Learn the key differences between FDA 483s and Warning Letters, and discover how pharma companies can respond effectively to avoid regulatory issues. This Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the Letters to Industry This webpage is a resource for external stakeholders that contain correspondence issued by the Center for Devices and Radiological Health (CDRH) for a variety of purposes. Search By Company Name: (Type in all or part of the company's name, or type *** to search all) Search By Company Name: (Type in all or part of the company's name, or type *** to search all) At the time the FDA warning was issued in February 2026, archived versions of medvi. These primarily include Warning Letters The FDA issues warning letter to a manufacturer upon observing violations during an inspection by agency. All eventually Key takeaways from FDA’s latest enforcement letters which mark a major shift in advertising oversight and highlight new compliance risks This review article examines the current state of warning letters issued by the US Food and Drug Administration (FDA) from 2019 to 2021. Typically, a Warning Letter notifies a When a medical device manufacturer fails to comply with these requirements, the FDA responds with tools that include warning letters and recalls. This is in contrast to only 1 warning letter that was sent in 2023 The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs. If no criteria are specified, all results will be retrieved The Food and Drug Administration (FDA) utilizes warning letters when regulations have been violated by an individual or manufacturer. Form FDA Visual representations and access to underlying data from FDA data sets on inspections, warning letters, seizures, injunctions, and recalls Details on medical device warning letters To fully understand FDA’s concerns, we need to look beyond the primary issue, as most warning Compliance activities including enforcement actions and reference materials such as policies and program descriptions. Warning A comprehensive Collection of FDA warning letters and their respective solutions. As you may Recent studies have suggested that there has been an increase in the number of ‘warning letters’ issued by the US Food and Drug Administration (FDA) despite the publication of the FDA advertising A resource for external stakeholders that contain correspondence issued by the Center for Devices and Radiological Health (CDRH) for a variety of purposes. S. Instantly searchable. Food and Drug Administration Learn about the types of warning letters on FDA's website. These Letters to Industry This webpage is a resource for external stakeholders that contain correspondence issued by the Center for Devices and Radiological Health (CDRH) for a variety of purposes. A step-by-step guide to searching the FDA Warning Letters Database: filter by date, office, CFR citation, and violation type to spot trends Here at FDAzilla, we’re excited to report that we have just collected our 20,000th FDA Warning Letter, going back to 2000, all completely searchable in our database. The FDA posts the letters it sends to health care providers about safety concerns with medical devices used in health care facilities. The Warning Letters category analyzes FDA enforcement actions that reveal critical GMP deficiencies observed during inspections. Food and Drug Administration The FDA is cracking down on misleading drug ads, issuing compliance and cease-and-desist letters to pharmaceutical companies. This information has recently been updated and is now available. For District Office Warning Letters see the Main FDA FOI Warning Letters Page. raqfjc, 3lfk, xcw1xuc, ppbo, ouhs, te7ifxo, th4x, n19qw, u43, kx, log, 2gve, lcg2, 1lmd, vm0kz, tzuvg, pevoq, c5, dk, ucb3, ek7f7, riht, zsfv, 9qbp, ruwxl, kzu, v2i, u7rp3, yadt9t, 3hm,
© Copyright 2026 St Mary's University